Andrea Tan
Stock Analyst at Goldman Sachs
(0.79)
# 3,737
Out of 4,840 analysts
45
Total ratings
31.43%
Success rate
-15.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $1.78 | +349.44% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $43.05 | +18.47% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $6.27 | +330.62% | 6 | Mar 25, 2025 | |
| INSM Insmed | Maintains: Buy | $74 → $102 | $67.53 | +51.04% | 9 | Jul 10, 2024 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $3.45 | +73.91% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $15.13 | +104.89% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $0.64 | +212.79% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $3.44 | -41.86% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $125.05 | +27.95% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $1.97 | +1,118.27% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.16 | +244.83% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $267.56 | +40.16% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $13 | $4.36 | +198.17% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $0.18 | +2,165.01% | 2 | May 24, 2022 |
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $1.78
Upside: +349.44%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $43.05
Upside: +18.47%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $6.27
Upside: +330.62%
Insmed
Jul 10, 2024
Maintains: Buy
Price Target: $74 → $102
Current: $67.53
Upside: +51.04%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $3.45
Upside: +73.91%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $15.13
Upside: +104.89%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $0.64
Upside: +212.79%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $3.44
Upside: -41.86%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $125.05
Upside: +27.95%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $1.97
Upside: +1,118.27%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.16
Upside: +244.83%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $267.56
Upside: +40.16%
Dec 15, 2022
Initiates: Sell
Price Target: $13
Current: $4.36
Upside: +198.17%
May 24, 2022
Maintains: Neutral
Price Target: $6 → $4
Current: $0.18
Upside: +2,165.01%